Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production(Front. Immunol., (2018), 9, (2370), 10.3389/fimmu.2018.02370)

Can Li; Kelvin K.W. To; Anna J.X. Zhang; Andrew C.Y. Lee; Houshun Zhu; Winger W.N. Mak; Ivan F.N. Hung; Kwok Yung Yuen

doi:10.3389/fimmu.2022.1053779

Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production(Front. Immunol., (2018), 9, (2370), 10.3389/fimmu.2018.02370)

Can Li, Kelvin K.W. To, Anna J.X. Zhang, Andrew C.Y. Lee, Houshun Zhu, Winger W.N. Mak, Ivan F.N. Hung, Kwok Yung Yuen

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the published article, there were errors in Figure 8 as published. The images of ELISPOT for PBS control treatment in Figure 8B, C and D were duplicated. The image of mdLN IgG ELISPOT in IMQ group (Figure 8B) was duplicated with spleen IgM in IMQ group (Figure 8A). The corrected Figure 8 and its caption appear below.The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Original language	English
Article number	1053779
Journal	Frontiers in Immunology
Volume	13
DOIs	https://doi.org/10.3389/fimmu.2022.1053779
Publication status	Published - Oct 21 2022
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2022 Li, To, Zhang, Lee, Zhu, Mak, Hung and Yuen.

ASJC Scopus Subject Areas

Immunology and Allergy
Immunology

Keywords

A(H1N1)pdm09
B cell
TLR7
imiquimod
inactivated influenza
mouse
peritoneal

Access to Document

10.3389/fimmu.2022.1053779

Cite this

Li, C., To, K. K. W., Zhang, A. J. X., Lee, A. C. Y., Zhu, H., Mak, W. W. N., Hung, I. F. N., & Yuen, K. Y. (2022). Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production(Front. Immunol., (2018), 9, (2370), 10.3389/fimmu.2018.02370). Frontiers in Immunology, 13, Article 1053779. https://doi.org/10.3389/fimmu.2022.1053779

Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production(Front. Immunol., (2018), 9, (2370), 10.3389/fimmu.2018.02370). / Li, Can; To, Kelvin K.W.; Zhang, Anna J.X. et al.
In: Frontiers in Immunology, Vol. 13, 1053779, 21.10.2022.

Research output: Contribution to journal › Comment/debate › peer-review

Li, C, To, KKW, Zhang, AJX, Lee, ACY, Zhu, H, Mak, WWN, Hung, IFN & Yuen, KY 2022, 'Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production(Front. Immunol., (2018), 9, (2370), 10.3389/fimmu.2018.02370)', Frontiers in Immunology, vol. 13, 1053779. https://doi.org/10.3389/fimmu.2022.1053779

Li C, To KKW, Zhang AJX, Lee ACY, Zhu H, Mak WWN et al. Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production(Front. Immunol., (2018), 9, (2370), 10.3389/fimmu.2018.02370). Frontiers in Immunology. 2022 Oct 21;13:1053779. doi: 10.3389/fimmu.2022.1053779

@article{2e8ad43bc6f74b2f838b82991957aed5,

title = "Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production(Front. Immunol., (2018), 9, (2370), 10.3389/fimmu.2018.02370)",

abstract = "In the published article, there were errors in Figure 8 as published. The images of ELISPOT for PBS control treatment in Figure 8B, C and D were duplicated. The image of mdLN IgG ELISPOT in IMQ group (Figure 8B) was duplicated with spleen IgM in IMQ group (Figure 8A). The corrected Figure 8 and its caption appear below.The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.",

keywords = "A(H1N1)pdm09, B cell, TLR7, imiquimod, inactivated influenza, mouse, peritoneal",

author = "Can Li and To, {Kelvin K.W.} and Zhang, {Anna J.X.} and Lee, {Andrew C.Y.} and Houshun Zhu and Mak, {Winger W.N.} and Hung, {Ivan F.N.} and Yuen, {Kwok Yung}",

note = "Publisher Copyright: {\textcopyright} 2022 Li, To, Zhang, Lee, Zhu, Mak, Hung and Yuen.",

year = "2022",

month = oct,

day = "21",

doi = "10.3389/fimmu.2022.1053779",

language = "English",

volume = "13",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media SA",

}

TY - JOUR

T1 - Corrigendum

T2 - Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production(Front. Immunol., (2018), 9, (2370), 10.3389/fimmu.2018.02370)

AU - Li, Can

AU - To, Kelvin K.W.

AU - Zhang, Anna J.X.

AU - Lee, Andrew C.Y.

AU - Zhu, Houshun

AU - Mak, Winger W.N.

AU - Hung, Ivan F.N.

AU - Yuen, Kwok Yung

PY - 2022/10/21

Y1 - 2022/10/21

N2 - In the published article, there were errors in Figure 8 as published. The images of ELISPOT for PBS control treatment in Figure 8B, C and D were duplicated. The image of mdLN IgG ELISPOT in IMQ group (Figure 8B) was duplicated with spleen IgM in IMQ group (Figure 8A). The corrected Figure 8 and its caption appear below.The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

AB - In the published article, there were errors in Figure 8 as published. The images of ELISPOT for PBS control treatment in Figure 8B, C and D were duplicated. The image of mdLN IgG ELISPOT in IMQ group (Figure 8B) was duplicated with spleen IgM in IMQ group (Figure 8A). The corrected Figure 8 and its caption appear below.The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

KW - A(H1N1)pdm09

KW - B cell

KW - TLR7

KW - imiquimod

KW - inactivated influenza

KW - mouse

KW - peritoneal

UR - http://www.scopus.com/inward/record.url?scp=85141393105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85141393105&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2022.1053779

DO - 10.3389/fimmu.2022.1053779

M3 - Comment/debate

C2 - 36341429

AN - SCOPUS:85141393105

SN - 1664-3224

VL - 13

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 1053779

ER -

Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production(Front. Immunol., (2018), 9, (2370), 10.3389/fimmu.2018.02370)

Abstract

Bibliographical note

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Cite this